Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Medroxyprogesterone acetate
Drug ID BADD_D01366
Description Medroxyprogesterone acetate (MPA) is a [progesterone] derivative that is more resistant to metabolism for improved pharmacokinetic properties.[A14848] MPA can be use to treat secondary amenorrhea, endometrial hyperplasia, abnormal uterine bleeding, osteoporosis, vasomotor symptoms in menopause, vulvar and vaginal atrophy, prevent pregnancy, manage pain in endometriosis, prevent pregnancy, and is also used in palliative care for endometrial and renal carcinoma.[L8657,L8660,L8663,L8666,L8669] Medroxyprogesterone acetate was granted FDA approval on 18 June 1959.[L8657]
Indications and Usage Used as a contraceptive and to treat secondary amenorrhea, abnormal uterine bleeding, pain associated with endometriosis, endometrial and renal cell carcinomas, paraphilia in males, GnRH-dependent forms of precocious puberty, as well as to prevent endometrial changes associated with estrogens.
Marketing Status Prescription; Discontinued
ATC Code G03AC06; G03DA02; L02AB02
DrugBank ID DB00603
KEGG ID D00951
MeSH ID D017258
PubChem ID 6279
TTD Drug ID Not Available
NDC Product Code 52221-118; 55289-816; 16714-999; 67457-887; 50090-0491; 55289-908; 0009-0065; 59762-0055; 59762-4537; 63629-8826; 68071-4666; 51927-0112; 63592-0089; 43063-438; 50090-0883; 50090-5619; 50090-5925; 50102-591; 62756-091; 0009-0051; 0548-5400; 51552-0790; 77044-5035; 50090-5747; 63629-2612; 0009-7376; 63629-8744; 0548-5701; 70518-3070; 0009-0286; 0009-5097; 0548-5711; 0009-0746; 53002-3570; 0555-0779; 68071-4132; 50090-4251; 59762-3740; 71205-118; 68071-1870; 59762-3741; 60687-105; 50090-3328; 0548-5410; 66993-371; 0703-6801; 0555-0873; 59762-0058; 50090-0490; 16714-028; 67296-0396; 50090-0166; 38779-1422; 72789-043; 46439-8712; 55289-160; 0555-0872; 68788-8112; 66993-370; 65089-0022; 49452-4725; 68788-9899; 60722-1006; 46439-8749; 63187-382; 63629-8824; 69097-539; 0009-4709; 70518-1932; 12866-1099; 59762-4538; 63629-2613; 59762-3742; 70518-3336; 62756-090; 62991-1474; 16714-981; 63629-8825; 0009-0287; 59762-0056
Synonyms Medroxyprogesterone Acetate | 6-alpha-Methyl-17alpha-hydroxyprogesterone Acetate | 6 alpha Methyl 17alpha hydroxyprogesterone Acetate | Depo-Medroxyprogesterone Acetate | Depo Medroxyprogesterone Acetate | (6 alpha)-17-(Acetoxy)-6-methylpregn-4-ene-3,20-dione | Pregn-4-ene-3,20-dione, 17-(acetyloxy)-6-methyl-, (6alpha)- | Medroxyprogesterone 17-Acetate | Medroxyprogesterone 17 Acetate | Depo-Provera | Depo Provera | DepoProvera | Farlutal | Gestapuran | Curretab | Medroxyprogesterone 17-Acetate, (6 beta)-Isomer | Perlutex | Provera | Veramix | Cycrin | Medroxyprogesterone 17-Acetate, (6 alpha,17 alpha)-Isomer
Chemical Information
Molecular Formula C24H34O4
CAS Registry Number 71-58-9
SMILES CC1CC2C(CCC3(C2CCC3(C(=O)C)OC(=O)C)C)C4(C1=CC(=O)CC4)C
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal discomfort07.01.06.001--Not Available
Abdominal distension07.01.04.0010.003319%
Abdominal pain07.01.05.0020.005617%
Abdominal pain lower07.01.05.010--Not Available
Abdominal pain upper07.01.05.003--
Abortion18.01.01.0010.000766%Not Available
Abortion missed18.01.01.002--Not Available
Abortion spontaneous18.01.04.0010.005362%Not Available
Abscess11.01.08.001--Not Available
Acne23.02.01.0010.000766%Not Available
Acute leukaemia16.01.02.001; 01.10.02.001--Not Available
Acute psychosis19.03.01.001--Not Available
Acute respiratory distress syndrome22.01.03.001--
Adrenal disorder05.01.03.001--Not Available
Affective disorder19.04.04.001--Not Available
Aggression19.05.01.0010.000766%Not Available
Agitation17.02.05.012; 19.06.02.001--
Alanine aminotransferase increased13.03.01.003--
Alcohol intolerance14.02.01.0010.000133%
Alopecia23.02.02.001--
Amenorrhoea21.01.02.001; 05.05.01.0020.007149%
Amnesia19.20.01.001; 17.03.02.0010.000511%
Anaemia01.03.02.001--
Anaphylactic reaction24.06.03.006; 10.01.07.0010.003064%
Anaphylactic shock24.06.02.004; 10.01.07.0020.000200%Not Available
Anaphylactoid reaction24.06.03.007; 10.01.07.003--Not Available
Anencephaly03.10.03.001; 17.19.03.001--Not Available
Angioedema23.04.01.001; 10.01.05.0090.001021%Not Available
Anorgasmia19.08.01.001--
Anosmia22.04.03.006; 17.04.04.001--
The 1th Page    1 2 3 4 5    Next   Last    Total 19 Pages